Fast Five Quiz: Primary Hyperoxaluria Type 1 Screening and Diagnosis

Bradley Schwartz, DO


March 04, 2022

Figure 1. Stage 5 kidney disease.

Guidelines for the screening and diagnosis of PH1 suggest that metabolic screening for PH1 be initiated when patients present with recurrent or familial stone disease. In cases where nephrocalcinosis is detected, PH1 screening is also recommended.

Learn more about screening for and diagnosing PH1.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.